Alternate Health Corp. Share Price

Equities

AHGIF

CA02090B1022

Pharmaceuticals

Delayed OTC Markets 19:29:19 16/01/2024 GMT 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Alternate Health Corp. -.--% -.--%

Financials

Sales 2017 13.25M 9.71M 773M Sales 2018 577K 423K 33.65M Capitalization 22.67M 16.61M 1.32B
Net income 2017 -26M -19.05M -1.52B Net income 2018 -24M -17.58M -1.4B EV / Sales 2017 6.25 x
Net cash position 2017 893K 654K 52.04M Net cash position 2018 773K 566K 45.05M EV / Sales 2018 37.9 x
P/E ratio 2017
-3.04 x
P/E ratio 2018
-0.76 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.35
3 years
0.00
Extreme 0
0.75
5 years
0.00
Extreme 0
0.75
10 years
0.00
Extreme 0
6.50
More quotes
Managers TitleAgeSince
Founder - 10/12/18
Director of Finance/CFO - 24/01/18
Chairman - 04/04/17
Members of the board TitleAgeSince
Director/Board Member - 15/04/15
Chairman - 04/04/17
Founder - 10/12/18
More insiders
Alternate Health Corp. is a Canada-based hemp-derived cannabidiol (CBD) company. The Company manufactures, packages, and distributes pharmaceutical grade products across the United States. It is a diverse healthcare provider that uses technology and data analytics for patient care and research in the CBD industry. Through its subsidiaries, it offers services ranging from medical practice and management software, clinical research and continuing education programs. Its products line includes topical creams and tinctures for the treatment of pain, scares, and fungus. It also manufactures and distributes Hempnesic, which is a hemp-based pain management cream. The Company's software systems provide the platform for its diverse operations, including CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection systems, education modules and electronic medical records (EMR) platforms. Its subsidiaries include Alternate Health, Inc. and Alternate Health USA Inc.
More about the company